ZEUS System (Zio Watch) vs VX1+
AI Verdict
Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System if you require long-term, continuous cardiac monitoring for a patient in an outpatient setting. This tool is ideal for detecting and characterizing atrial fibrillation burden and other cardiac arrhythmias over an extended period, providing actionable insights for diagnosis and ongoing management.
View ZEUS System (Zio Watch) →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia. This AI-powered software provides real-time identification of abnormal electrograms, assisting in guiding the ablation process to improve procedural success and patient outcomes.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System (Zio Watch) | VX1+ |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Cloud-based system with a wearable device | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool A (ZEUS System) offers a broader usability profile, catering to both patients with a wearable device and a mobile app for symptom logging, and providers with a portal and mobile app for report interpretation. Tool B (VX1+) is highly specialized for electrophysiologists during complex ablation procedures, requiring integration with existing EP systems, making its general usability narrower despite a simple interface.
Clinical Value
VX1+Both tools are FDA-cleared and offer significant clinical value. However, Tool B (VX1+) has demonstrated superior efficacy in improving patient outcomes for persistent atrial fibrillation ablation in the TAILORED-AF trial, showing a higher rate of freedom from AF at 12 months compared to standard care. Tool A provides valuable diagnostic and monitoring insights with high physician agreement, but Tool B directly impacts the success of an interventional procedure with strong outcome data.
Pricing & Value
TieNeither tool provides publicly available pricing information, making a direct comparison of their cost-effectiveness impossible. Both offer substantial clinical value in their respective domains, but without transparent pricing, a 'value for money' assessment cannot be made.
Enterprise Readiness
ZEUS System (Zio Watch)Tool A (ZEUS System) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. While Tool B (VX1+) implies these are expected for a medical device, Tool A's explicit confirmation and its established presence as iRhythm Technologies suggest a more robust and proven enterprise infrastructure and compliance framework.
Innovation
VX1+Both tools are innovative. However, Tool B (VX1+) stands out for its real-time AI-powered assistance during complex cardiac ablation procedures, directly guiding electrophysiologists in identifying abnormal electrograms in a dynamic surgical environment. This application of AI to directly influence an invasive procedure in real-time represents a highly specialized and impactful innovation.
Support & Docs
TieThe provided structured facts and general web searches do not offer sufficient specific details regarding the quality, breadth, or accessibility of support channels and documentation for either tool. While both companies likely offer support, there is no comparative information to distinguish a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System (Zio Watch) | VX1+ |
|---|---|---|
| Name | ZEUS System (Zio Watch) | VX1+ |
| Company | iRhythm Technologies | Volta Medical |
| Description | FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Primary Use Case | Long-term continuous cardiac monitoring for arrhythmia detection (AFib) | Real-time identification of abnormal electrograms during cardiac ablation procedures |
| Key Features (Example 1) | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection | Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart |
| Key Features (Example 2) | AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis | Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and VX1+.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System (Zio Watch) or VX1+
Backers
Who funded each tool's parent company.